These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 7738206)
41. Thrombin Provokes Degranulation of Platelet α-Granules Leading to the Release of Active Plasminogen Activator Inhibitor-1 (PAI-1). Huebner BR; Moore EE; Moore HB; Stettler GR; Nunns GR; Lawson P; Sauaia A; Kelher M; Banerjee A; Silliman CC Shock; 2018 Dec; 50(6):671-676. PubMed ID: 29280928 [TBL] [Abstract][Full Text] [Related]
42. PAI-1 inhibition enhances the lysis of the platelet-rich part of arterial-like thrombi formed in vitro. A comparative study using thrombi prepared from rat and human blood. van Giezen JJ; Nerme V; Abrahamsson T Blood Coagul Fibrinolysis; 1998 Jan; 9(1):11-8. PubMed ID: 9607114 [TBL] [Abstract][Full Text] [Related]
43. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator. Sitter T; Toet K; Quax P; Kooistra T Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120 [TBL] [Abstract][Full Text] [Related]
44. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles. Rupin A; Martin F; Vallez MO; Bonhomme E; Verbeuren TJ Thromb Haemost; 2001 Dec; 86(6):1528-31. PubMed ID: 11776323 [TBL] [Abstract][Full Text] [Related]
45. Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1. Rezaie AR Biochemistry; 1998 Sep; 37(38):13138-42. PubMed ID: 9748320 [TBL] [Abstract][Full Text] [Related]
46. Monocyte-macrophage release of IL-1 is inhibited by type-1 plasminogen activator inhibitors. Robson SC; Saunders R; Kirsch RE J Clin Lab Immunol; 1990 Oct; 33(2):83-90. PubMed ID: 1967070 [TBL] [Abstract][Full Text] [Related]
48. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis. van Giezen JJ; Boon GI; Jansen JW; Bouma BN Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851 [TBL] [Abstract][Full Text] [Related]
49. High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi. Fay WP; Murphy JG; Owen WG Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1277-84. PubMed ID: 8857925 [TBL] [Abstract][Full Text] [Related]
50. Characterisation of the complex of plasminogen activator inhibitor type 1 with tissue-type plasminogen activator by mass spectrometry and size-exclusion chromatography. Strömqvist M; Karlsson KE; Björquist P; Andersson JO; Byström M; Hansson L; Johansson T; Deinum J Biochim Biophys Acta; 1996 Jun; 1295(1):103-9. PubMed ID: 8679667 [TBL] [Abstract][Full Text] [Related]
51. Plasminogen activator inhibitor type-1 interacts exclusively with the proteinase domain of tissue plasminogen activator. Björquist P; Brohlin M; Ehnebom J; Ericsson M; Kristiansen C; Pohl G; Deinum J Biochim Biophys Acta; 1994 Dec; 1209(2):191-202. PubMed ID: 7811690 [TBL] [Abstract][Full Text] [Related]
52. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Zhu Y; Carmeliet P; Fay WP Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124 [TBL] [Abstract][Full Text] [Related]
53. Lysis of plasma clots by urokinase-soluble urokinase receptor complexes. Higazi AA; Bdeir K; Hiss E; Arad S; Kuo A; Barghouti I; Cines DB Blood; 1998 Sep; 92(6):2075-83. PubMed ID: 9731065 [TBL] [Abstract][Full Text] [Related]
54. Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia. Pósán E; Ujj G; Kiss A; Telek B; Rák K; Udvardy M Thromb Res; 1998 Apr; 90(2):51-6. PubMed ID: 9684757 [TBL] [Abstract][Full Text] [Related]
55. Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling. Stefansson S; McMahon GA; Petitclerc E; Lawrence DA Curr Pharm Des; 2003; 9(19):1545-64. PubMed ID: 12871067 [TBL] [Abstract][Full Text] [Related]
56. Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop. Stringer HA; van Swieten P; Heijnen HF; Sixma JJ; Pannekoek H Arterioscler Thromb; 1994 Sep; 14(9):1452-8. PubMed ID: 8068607 [TBL] [Abstract][Full Text] [Related]
57. Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C. Rezaie AR J Biol Chem; 2001 May; 276(19):15567-70. PubMed ID: 11264280 [TBL] [Abstract][Full Text] [Related]
58. Effect of the small molecule plasminogen activator inhibitor-1 (PAI-1) inhibitor, PAI-749, in clinical models of fibrinolysis. Lucking AJ; Visvanathan A; Philippou H; Fraser S; Grant PJ; Connolly TM; Gardell SJ; Feuerstein GZ; Fox KA; Booth NA; Newby DE J Thromb Haemost; 2010 Jun; 8(6):1333-9. PubMed ID: 20345708 [TBL] [Abstract][Full Text] [Related]